A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network
- PMID: 22526900
- PMCID: PMC5262491
- DOI: 10.1245/s10434-012-2345-z
A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network
Abstract
Background: It is important to understand the relative importance of prognostic variables in patients with soft tissue sarcomas. The purpose of this study was to describe the hierarchical relationships between features inherent to completely excised, localized high-grade soft tissue sarcomas of the extremity and compare the associations to those previously reported.
Methods: Data were collected from the Memorial Sloan-Kettering Cancer Center Sarcoma Database. All adult patients with high-grade extremity soft tissue sarcomas who underwent complete excision (R0 margins) at our institution between 1982 and 2010 were included in the analysis. Bayesian belief network (BBN) modeling software was used to develop a hierarchical network of features trained to estimate the likelihood of disease-specific survival. Important relationships depicted by the BBN model were compared to those previously reported.
Results: The records of 1318 consecutive patients met the inclusion criteria, and all were included in the analysis. First-degree associates of disease-specific survival were the primary tumor size; presence of and time to distant recurrence; and presence of and time to local recurrence. On cross-validation, the BBN model was sufficiently robust, with an area under the curve of 0.94 (95 % confidence interval 0.93-0.96).
Conclusions: We successfully described the hierarchical relationships between features inherent to patients with completely excised high-grade soft tissue sarcomas of the extremity. The relationships defined by the BBN model were similar to those previously reported. Cross-validation results were encouraging, demonstrating that BBN modeling can be used to graphically illustrate the complex hierarchical relationships between prognostic features in this setting.
Figures

Similar articles
-
Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?Clin Orthop Relat Res. 2017 Jun;475(6):1681-1689. doi: 10.1007/s11999-017-5346-1. Epub 2017 Apr 10. Clin Orthop Relat Res. 2017. PMID: 28397168 Free PMC article.
-
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?Clin Orthop Relat Res. 2017 May;475(5):1427-1435. doi: 10.1007/s11999-017-5232-x. Epub 2017 Jan 12. Clin Orthop Relat Res. 2017. PMID: 28083752 Free PMC article.
-
Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract.Clin Orthop Relat Res. 2013 Mar;471(3):891-8. doi: 10.1007/s11999-012-2569-z. Clin Orthop Relat Res. 2013. PMID: 22968531 Free PMC article.
-
Soft-tissue sarcomas in dogs: a review.J Am Anim Hosp Assoc. 2005 Jul-Aug;41(4):241-6. doi: 10.5326/0410241. J Am Anim Hosp Assoc. 2005. PMID: 15995161 Review.
-
Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.Jpn J Clin Oncol. 2021 Feb 8;51(2):180-184. doi: 10.1093/jjco/hyaa231. Jpn J Clin Oncol. 2021. PMID: 33313851 Review.
Cited by
-
Lessons learned from the study of 10,000 patients with soft tissue sarcoma.Ann Surg. 2014 Sep;260(3):416-21; discussion 421-2. doi: 10.1097/SLA.0000000000000869. Ann Surg. 2014. PMID: 25115417 Free PMC article.
-
Development and comparison of 1-year survival models in patients with primary bone sarcomas: External validation of a Bayesian belief network model and creation and external validation of a new gradient boosting machine model.SAGE Open Med. 2022 Feb 8;10:20503121221076387. doi: 10.1177/20503121221076387. eCollection 2022. SAGE Open Med. 2022. PMID: 35154743 Free PMC article.
-
Toward better soft tissue sarcoma staging: building on american joint committee on cancer staging systems versions 6 and 7.Ann Surg Oncol. 2013 Oct;20(11):3377-83. doi: 10.1245/s10434-013-3052-0. Epub 2013 Jun 18. Ann Surg Oncol. 2013. PMID: 23775410 Free PMC article. Clinical Trial.
-
CORR Insights®: Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?Clin Orthop Relat Res. 2018 Mar;476(3):645-647. doi: 10.1007/s11999.0000000000000184. Clin Orthop Relat Res. 2018. PMID: 29443851 Free PMC article. No abstract available.
-
Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?Clin Orthop Relat Res. 2017 Jun;475(6):1681-1689. doi: 10.1007/s11999-017-5346-1. Epub 2017 Apr 10. Clin Orthop Relat Res. 2017. PMID: 28397168 Free PMC article.
References
-
- Collin C, Hadju SI, Godbold J, Shiu MH, Hilaris BI, Brennan MF. Localized, operable soft tissue sarcoma of the lower extremity. Arch Surg. 1986;121:1425–1433. - PubMed
-
- Collin CF, Friedrich C, Godbold J, Hajdu S, Brennan MF. Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma. Semin Surg Oncol. 1988;4:30–37. - PubMed
-
- Torosian MH, Friedrich C, Godbold J, Hajdu SI, Brennan MF. Soft-tissue sarcoma: Initial characteristics and prognostic factors in patients with and without metastatic disease. Semin Surg Oncol. 1988;4:13–19. - PubMed
-
- Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–1689. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous